Biogen, Inc. (BIIB)
253.62
+3.97
(+1.59%)
USD |
NASDAQ |
Oct 30, 16:00
254.10
+0.48
(+0.19%)
After-Hours: 20:00
Biogen 30-Day Average Daily Volume : 1.299M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.299M |
| October 29, 2026 | 1.344M |
| October 28, 2026 | 1.333M |
| October 27, 2026 | 1.270M |
| October 26, 2026 | 1.249M |
| October 23, 2026 | 1.238M |
| October 22, 2026 | 1.235M |
| October 21, 2026 | 1.192M |
| October 20, 2026 | 1.188M |
| October 19, 2026 | 1.159M |
| October 16, 2026 | 1.142M |
| October 15, 2026 | 1.112M |
| October 14, 2026 | 1.102M |
| October 13, 2026 | 1.063M |
| October 12, 2026 | 1.056M |
| October 09, 2026 | 1.024M |
| October 08, 2026 | 1.014M |
| October 07, 2026 | 990716.3 |
| October 06, 2026 | 963957.5 |
| October 05, 2026 | 952015.2 |
| October 02, 2026 | 944382.8 |
| October 01, 2026 | 945322.7 |
| September 30, 2026 | 916370.1 |
| September 29, 2026 | 887726.1 |
| September 28, 2026 | 869594.9 |
| Date | Value |
|---|---|
| September 25, 2026 | 843677.4 |
| September 24, 2026 | 840412.9 |
| September 23, 2026 | 832236.2 |
| September 22, 2026 | 813647.7 |
| September 21, 2026 | 800117.1 |
| September 18, 2026 | 797183.9 |
| September 17, 2026 | 739073.4 |
| September 16, 2026 | 740309.2 |
| September 15, 2026 | 760282.9 |
| September 14, 2026 | 766447.8 |
| September 11, 2026 | 780858.7 |
| September 10, 2026 | 774771.4 |
| September 09, 2026 | 823555.8 |
| September 08, 2026 | 861472.8 |
| September 04, 2026 | 866297.8 |
| September 03, 2026 | 870673.3 |
| September 02, 2026 | 886717.5 |
| September 01, 2026 | 872486.4 |
| August 31, 2026 | 868064.5 |
| August 28, 2026 | 872467.3 |
| August 27, 2026 | 893594.0 |
| August 26, 2026 | 939435.8 |
| August 25, 2026 | 986769.6 |
| August 24, 2026 | 1.100M |
| August 21, 2026 | 1.154M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AbbVie, Inc. | 4.796M |
| Gilead Sciences, Inc. | 5.928M |
| Amgen, Inc. | 2.742M |
| Eli Lilly & Co. | 2.448M |
| Regeneron Pharmaceuticals, Inc. | 753586.4 |